Publication | Open Access
<i>MSH6</i> Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance
378
Citations
28
References
2009
Year
MSH6 mutations are selected in glioblastomas during temozolomide therapy both in vitro and in vivo and are causally associated with temozolomide resistance.
| Year | Citations | |
|---|---|---|
Page 1
Page 1